The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...

Xoma Royalty is acquiring the pharmaceutical company Generation Bio. Xoma, a biotechnology-royalty aggregator, said Monday that it would pay roughly $4.29 a share for the company.

Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna -- Generation ...

Option traders moderately bearish in Moderna (MRNA), with shares down 12c near $29.34. Options volume relatively light with 19k contracts traded ...

NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

The U.S. Food and Drug Administration is considering adding the strongest safety warning available to COVID-19 vaccines, ...

Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...

A worker readies syringes with the Moderna COVID-19 vaccine ...

Such warnings are reserved for medications that carry risks of death or life-threatening reactions.

A number of diseases tend to peak in the winter, thanks to indoor gatherings that help germs spread. The list includes not ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.